Contract 75H71119F27001
Emergent Devices, Inc. · Department Of Health And Human Services · September 2, 2021
Emergent Devices, Inc. was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on September 2, 2021 for $145,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Wayne, PA. This is a task or delivery order issued under parent IDIQ 75H71119A00116. It was awarded under a small business set-aside. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 9, 2021. If all options are exercised, the contract could reach $145,000.
Contract details
- PIID
- 75H71119F27001
- Parent IDIQ
- 75H71119A00116
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Wayne, PA
- First action
- September 2, 2021
- Latest action
- September 9, 2021
Description
BPA CALL TO PURCHASE NARCAN NASAL SPRAY FOR NSSC WAREHOUSE CUSTOMERS.
Modification timeline
-
September 9, 2021Mod P00001 · Close Out$144.6K
-
September 2, 2021Mod P00001 · Close OutCLOSE OUT FAR 4.804-1$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71119F27001?
Contract 75H71119F27001 is a federal contract awarded to Emergent Devices, Inc. by Department Of Health And Human Services on September 2, 2021 for $145,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75H71119F27001?
Emergent Devices, Inc. won contract 75H71119F27001 from Department Of Health And Human Services.
How much is contract 75H71119F27001 worth?
Contract 75H71119F27001 has obligated $0 to date but carries a potential ceiling of $145,000 if fully funded and all options are exercised.